Surprise finding could lead to new MS treatments
from University of Alberta Faculty of Medicine & Dentistry via ScienceDaily
A discovery is providing hope of a new therapeutic target in multiple sclerosis patients that could one day be used to prevent the symptoms and progression of the disease. By removing a protein called calnexin in mice, researchers found the mice were provided with full protection from the mouse model of MS — known as experimental autoimmune encephalomyelitis.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063